BCAL Diagnostics (ASX:BDX) Price-to-Tangible-Book : 5.21 (As of Jun. 07, 2024)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Price-to-Tangible-Book?

As of today (2024-06-07), BCAL Diagnostics's share price is A$0.125. BCAL Diagnostics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.02. Hence, BCAL Diagnostics's Price to Tangible Book Ratio of today is 5.21.

The historical rank and industry rank for BCAL Diagnostics's Price-to-Tangible-Book or its related term are showing as below:

ASX:BDX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.46 Med: 1.74 Max: 8.75
Current: 6.25

During the past 2 years, BCAL Diagnostics's highest Price to Tangible Book Ratio was 8.75. The lowest was 1.46. And the median was 1.74.

ASX:BDX's Price-to-Tangible-Book is ranked worse than
78.66% of 164 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.495 vs ASX:BDX: 6.25

A closely related ratio is called PB Ratio. As of today, BCAL Diagnostics's share price is A$0.125. BCAL Diagnostics's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.02. Hence, BCAL Diagnostics's P/B Ratio of today is 5.21.

BCAL Diagnostics Price-to-Tangible-Book Historical Data

The historical data trend for BCAL Diagnostics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Price-to-Tangible-Book Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Price-to-Tangible-Book

1.74

2.80

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial			1.46	1.74	1.67	2.80	4.17

Competitive Comparison of BCAL Diagnostics's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, BCAL Diagnostics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BCAL Diagnostics's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's Price-to-Tangible-Book falls into.

BCAL Diagnostics Price-to-Tangible-Book Calculation

BCAL Diagnostics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.125	/	0.024
	=	5.21

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

BCAL Diagnostics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.